Welcome! Get free delivery from €130+ orders Learn More

Saxenda Pen

$ 213

Buy the Saxenda Pen, a convenient once-daily liraglutide injection pen for chronic weight management in adults and adolescents. This easy-to-use pre-filled pen helps suppress appetite, increase fullness, and support significant, sustained weight loss when paired with a reduced-calorie diet and increased physical activity. Perfect for obesity or overweight with related health conditions.

In Stock

-
+
Add to Wishlist
Add to Wishlist

Description

Whats is The Saxenda Pen?

The Saxenda Pen (liraglutide injection 3 mg) is an FDA-approved, user-friendly pre-filled pen device delivering a prescription medication specifically designed for long-term weight management in adults with obesity (BMI ≥30) or overweight (BMI ≥27) with at least one weight-related comorbidity such as hypertension, type 2 diabetes, dyslipidemia, or obstructive sleep apnea, as well as adolescents aged 12 years and older with obesity (body weight >60 kg/132 lbs). As a potent GLP-1 receptor agonist, Saxenda Pen mimics the natural incretin hormone GLP-1 to regulate appetite by slowing gastric emptying, decreasing hunger, and enhancing feelings of satiety, enabling patients to reduce calorie intake and achieve meaningful, lasting weight loss. Clinical trials from the SCALE program demonstrate that Saxenda Pen, when combined with lifestyle interventions, results in average weight reductions of 5-10% or more of initial body weight (often 12-25 pounds or greater) within the first year, with many individuals maintaining substantial loss and experiencing improvements in cardiovascular risk factors, blood pressure, cholesterol, and glycemic control. The intuitive Saxenda Pen features simple dial-up dosing, a hidden needle for discreet and comfortable administration, and once-daily subcutaneous injections (in the abdomen, thigh, or upper arm), starting at 0.6 mg and gradually increasing weekly to the full maintenance dose of 3.0 mg to promote better tolerability and minimize common side effects like nausea. This advanced delivery system eliminates the need for vial-and-syringe preparation, making Saxenda Pen an accessible and reliable choice for those committed to non-surgical weight management who have not achieved sufficient results through diet and exercise alone. Manufactured by Novo Nordisk to the highest pharmaceutical standards, the Saxenda Pen ensures precise dosing, consistent efficacy, and ease of use for sustainable obesity treatment and improved overall wellness. Always consult a healthcare provider before starting Saxenda Pen to confirm it is suitable for your health needs, receive comprehensive training on pen operation and dose titration, and discuss monitoring for side effects (such as transient gastrointestinal symptoms, injection-site reactions, or rare serious risks including pancreatitis or thyroid concerns).

ALSO READ